Text Word Count: 3973 2 ABSTRACT When blood is exposed to variety of artificial surfaces and biologic substances, the plasma proteins factor XII (FXII) and prekallikrein undergo reciprocal proteolytic conversion to the proteases FXIIa and -kallikrein by a process called contact activation. These enzymes contribute to host-defense responses including coagulation, inflammation, and fibrinolysis. The initiating event in contact activation is debated.
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(ILC Performance Products) of 60-100 unit chain length (not calcium saturated) was provided by Drs. [32] , FXIIa (559C-X181-D06 [D06]) [33] , and kallikrein (559A-M202-H03 [H03]) [33, 34] have been described. Goat polyclonal IgGs against FXII, PK, and FXI were from Affinity Biologicals.
Thomas Renné and Katrin Nikel (Karolinska Institute). Monoclonal IgGs to FXI (O1A6)
Recombinant Proteins. Schematic diagrams of human FXII, PK and FXI and their cleaved forms are shown in Fig.1A . A FXI cDNA with the active site serine replaced with alanine (FXI-S557A) was expressed in HEK293 cells using vector pJVCMV, purified by IgG affinity chromatography, and stored in 4 mM TrisHCl 150 mM NaCl pH 7.4 [35] . FXII [36] and PK [37] cDNAs were introduced into pJVCMV and expressed in HEK293 cells under serum free conditions (Supp. data 1). In addition to wild type FXII (FXII-WT), variants were made with alanine replacing arginine at each known cleavage site (FXII-R334A, FXII-R343A or FXII-R353A) or all three cleavage sites (FXII-T for "triple" mutant), or replacing the active site serine (FXII-S544A). Wild type PK (PK-WT) and variants with alanine replacing arginine at the activation site (PK-R371A) or the active site serine (PK-S559A) were also prepared. FXII and PK were purified by anion exchange chromatography (Fig.1B) as described under Supp. data 1. ). Km and kcat were determined by non-linear least squares fitting using Scientist Software (Micromath). (discontinuous assay).
Chromogenic assays (continuous assay
FXII activation (200 nM) with Poly-P (70 M) or α-kallikrein (50 nM), and PK (12.5 to 600 nM) cleavage by FXIIa (25 pM) or FXII-T (15 nM) were performed in standard buffer at 37 ºC. For FXII activation, reactions were stopped with Polybrene (0.1 mg/ml) with or without H03 (10 nM Thrombin Generation. Thrombin generation was measured in 96-well polypropylene plates on a Fluoroskan Ascent analyzer as described [35] . FXII-deficient plasma was supplemented with FXII (200 nM), 415 M Z-Gly-Gly-Arg-AMC, 1.6 M CTI or vehicle, 20 ug/ml of IgG O1A6 or vehicle, and PTT-A reagent (13% final volume). Supplemented plasma (40 l) was mixed with 10 l of 20 mM HEPES pH 7.4, 100 mM CaCl2, 6% BSA and fluorescence (excitation  390 nm, emission  460 nm) was monitored.
Carotid artery thrombosis model. Procedures with mice were approved by the Vanderbilt University
Animal Care and Use Committee. FXII-deficient C57Bl/6 mice [16] were anesthesthetized with 50 mg/kg IP pentobarbital. The right common carotid artery was exposed and fitted with a Doppler probe (Model 0.5 VB, Transonic System). FXII (25 g in 100 uL of PBS) was infused through the internal jugular vein. Five 6 minutes later two 1 x 1.5 mm filter papers (GB003, Schleicher & Schuell,) saturated with 5% FeCl3 were applied to opposite sides of the artery for three min [18] . Flow was monitored for 30 min.
RESULTS

FXII autoactivation.
FXII undergoes autocatalytic activation in the presence of several polyanions [17, 21, [26] [27] [28] [29] . The Coomassie-stained reducing gel in Fig.2A shows the 80 kDa FXII polypeptide undergoing autocatalysis in the presence of Poly-P, forming the 50 kDa heavy and 30 kDa light chains of FXIIa. The changes are accompanied by a rapid increase in amidolytic activity (Fig.2B) . FXII is cleaved at up to three sites during activation (after Arg334, Arg343, or Arg353 Fig.1A ). Cleavage after Arg353 is required for FXIIa generation [36, 38] . FXII species with Arg353 (FXII-WT, FXII-R334A. FXII-R343A) undergo autocatalysis in the presence of Poly-P, while species lacking Arg353 (FXII-R353A and FXII-T)
do not (Fig.2C , middle column). Loss of the catalytic active site serine (Ser544) [36] , as expected, also prevents autocatalysis (Fig.2C , middle column). Experiments examining cleavage of the tripeptide S-2302 support the western blot data, with amidolytic activity increasing in reactions with species that undergo conversion to FXIIa, but not in reactions with FXII-R353A, FXII-T or FXII-S544A (Fig.2D ). These data show that cleavage after Arg353 is required for full elaboration of FXII amidolytic activity.
FXII activation by -kallikrein. During contact activation, -kallikrein cleaves FXII after Arg353 forming FXIIa [36, 38] . Substitutions for Arg334 or Arg343 do not prevent this (Fig.2C , right column). -kallikrein also cleaves FXII-R353A (Fig.2C , right column); however, this does not increase amidolytic activity (Fig.2E) , indicating cleavage is after a residue other than 353. Because Arg353 replacement did not prevent FXII cleavage, we prepared FXII-T, which lacks all three known FXII cleavage sites. The failure of -kallikrein to cleave FXII-T (Fig.2C , right column) indicates -kallikrein cleaves FXII-R353A after Arg334 and/or Arg343. FXII-S544A, which has Arg353, is cleaved by -kallikrein (Fig.2C , right column) but, as expected, also lacks amidolytic activity because of the absence of Ser544 (Fig.2E ). We performed non-reducing western blots for reactions similar to those in the right hand column of Fig.2C using IgG D06, which preferentially recognizes fully formed FXIIa (Supp. data 2). Signals are detected 7 for forms of FXII that have arginine at position 353, but not form forms with alanine at this position. This confirms that when FXII-R353A is cleaved by kallikrein it does not assume a conformation similar to FXIIa. Cumulatively, the results support the premise that full FXIIa amidolytic activity requires cleavage after Arg353 and an active catalytic mechanism (i.e. Ser544).
Reciprocal FXII and PK activation. Mixing FXII and PK in the absence of a surface leads to cleavage of both proteins as revealed by reducing western blots (Fig.3A) . Each protein undergoes more than one
cleavage, but at least one involves the respective activation sites (after FXII Arg353 or PK Arg371) [38] . This is shown in the non-reducing blots in Fig.3B , which use antibodies that preferentially recognize fully formed FXIIa (D06) and kallikrein (H03) [33, 34] . Taken as a whole, the reducing and non-reducing blots indicate FXII is converted first to FXIIa (80 kDa) by cleavage after Arg353, then more slowly to FXIIa (30 kDa) by cleavage after Arg334 (Fig.1A) . PK is converted to -kallikrein by cleavage after Arg371, and then -kallikrein by cleavage after Arg140 (Fig.1A) , both of which are 90 kDa proteins (Fig.3B ) [37, 38] .
Mixing FXII-WT and PK-WT generates patterns similar to their plasma counterparts (Fig.3C ).
Unexpectedly, forms of FXII that do not form FXIIa (FXII-R353A and FXII-T) induce PK cleavage (Fig.3C) . The results could not be accounted for by endogenous FXII production by HEK293 cells, nor by non-FXII constituents of conditioned media (Supp. data 1). Furthermore, PK-WT was not cleaved by FXII-S544A ( Fig.3C ), indicating cleavage requires recombinant FXII with an intact FXII catalytic apparatus.
The variant PK-S559A, which lacks an active site serine, was also cleaved by FXII-R353A and FXII-T, indicating -kallikrein activity is not needed for PK cleavage in reactions with FXII-R353A and FXII-T (Supp. data 3). These data show that single-chain FXII has proteolytic activity.
S-2302 cleavage by single-chain FXII.
Single-chain FXII-WT cleaves S-2302 at a low rate (Fig.4A ). This is usually interpreted as reflecting traces of contaminating FXIIa, a possibility that cannot be ruled out.
However, FXII-R353A and FXII-T also consistently demonstrated low-level amidolytic activity, while FXII-S544A does not ( Consistent with observations that polyanions accelerate reciprocal FXII/PK activation [31, 33] , PK activation by FXII-T is enhanced by Poly-P (Fig.4H ).
Single-chain FXII catalyzes surface-dependent FXII activation. Neither FXII-T nor FXII-S544A undergo autocatalysis in the presence of Poly-P (Fig.2C ), the former because it lacks cleavage sites and the later because it lacks catalytic activity. When these proteins are mixed in the presence of a silica-based aPTT reagent or Poly-P ( Fig.5A ) there is a time-dependent increase in a signal on western blots using IgG D06, indicating formation of a species with a catalytic domain with similar conformation to FXIIa. Incubation of either protein alone with Poly-P does not produce a signal, consistent with results in Fig.2C (middle column). Of the two proteins, only FXII-S544A cleaved after Arg353 is recognized well by IgG D06 (Supp.
Data 2)
. Therefore, the results are most consistent with surface-induced FXII-T cleavage of FXII-S544A 9 after Arg353. The results indicate that single-chain FXII can initiate FXII activation after the protein is bound to an activating surface.
Single-chain FXII catalyzes surface-dependent FXI activation. FXIIa-mediated conversion of FXI to
FXIa is a key step in contact activation-initiated coagulation. In the following experiments FXI-S557A is used instead of FXI because the latter undergoes autoactivation when exposed to polyanions [35] making it difficult to assess the FXII contribution to FXI activation. In the absence of Poly-P, mixing FXI-S557A
with FXII-WT, FXII-T or FXII-S544A does not result in detectable FXI-S557A cleavage ( Fig.5B top row) .
With Poly-P ( These data are consistent with results from plasma the assays, and indicate that the relatively small amount of thrombin generated through the proteolytic activity of single-chain FXII is not sufficient to promote thrombosis in this model, and that FXIIa is required for full elaboration of protease activity.
DISCUSSION
FXII becomes active when blood is exposed to a variety of biologic and non-biologic substances, however, the mechanism that initiates activation is debated. Given the range of surfaces that support contact activation, different processes may operate in different situations [39] . In 1976, Griffin and Cochrane raised the question of whether a proteolytic or non-proteolytic process best explained initial FXII activity [40] .
Several groups proposed that FXII gains activity once surface-bound, and postulated that conversion to a two-chain form is not required in all circumstances [29] [30] [31] . Silverberg et al. [26, 27] and Tans et al. [28] came to a different conclusion. In their opinions FXIIa was the active form of FXII, and the sigmoidal progress curves for surface-dependent FXII autoactivation were most compatible with a process initiated by traces of FXIIa in FXII preparations. However, recognizing the difficulty of eliminating other possibilities with assays based on plasma-derived FXII, Silverberg and Kaplan suggested that if singlechain FXII had activity, it is weak, and calculated a limit on its ability to cleave the tripeptide S-2302 at <4200-fold that of FXIIa [27] .
In vivo, polymeric anions may serve as counterparts to the non-biologic substances traditionally used to study contact activation. One of the best characterized is Poly-P, polymers of inorganic phosphate that produce procoagulant effects in plasma including induction of contact activation [17, 21, 25, 41] . Engel et al.
recently reported that FXII bound to Poly-P chains of the size released by platelets cleaves S-2302 and activates PK and FXI without undergo conversion to FXIIa [31] , indicating Poly-P-binding induces conformational changes in single-chain FXII that confer activity. A striking finding in their study, which conflicts with the data presented here, was that the amidolytic activities of FXIIa and Poly-P-bound FXII were comparable, suggesting conversion to FXIIa is not necessary for full (or substantial) elaboration of protease activity. These experiments, and earlier work, used plasma FXII, making it difficult to exclude effects from FXIIa, either as an initial contaminant or as a product generated during reactions. We addressed this issue with recombinant FXII that cannot be converted to FXIIa. Our results show that single-chain FXII has activity and that Poly-P enhances that activity toward the macromolecular substrates PK, FXII and FXI. However, there are important differences between our results and those reported by Members of the trypsin-like protease family are usually secreted as inactive single-chain zymogens that require internal proteolysis after Arg15 (chymotrypsin numbering) for activity [42] . Upon cleavage, the new catalytic domain N-terminus (residue 16) forms a salt-bridge with Asp194, creating a functional substrate recognition site. Consistent with this, we observed that increased rates of S-2302 cleavage by FXII (plasma or recombinant) in the presence of Poly-P are associated with conversion to FXIIa. Arg353 in human FXII corresponds to chymotrypsin Arg15 [36, 38] , and replacing it blocks Poly-P-mediated FXII autocatalysis and the associated increase in amidolytic activity. These findings support the premise that polyanion-induced elaboration of full FXII activity involves cleavage after Arg353 [27, 28] . Our data with plasma-derived and recombinant FXII-WT are in disagreement with those of Engel et al. on this point.
Perhaps differences in preparative techniques for Poly-P, or methods for detecting FXIIa contribute to the discrepancy. We observed that Poly-P-based reactions behave differently depending on buffer conditions, which may be relevant. However, it is worth noting that forms of FXII that do not form FXIIa did not reconstitute FXII-deficient mice in a thrombosis model in which FXII and Poly-P play prominent roles [17, 25] . This argues against a mechanism in which binding of a cofactor converts FXII to a fully or substantially active protease without cleavage after Arg353, and is consistent with the marked decrease in activity of the natural variant FXII Locarno, in which proline replaces Arg353 [43] .
Single chain FXII-T cleaves S-2302 and activates PK without adding Poly-P or a surface, suggesting it has a low level of proteolytic activity when not surface-bound. Poly-P does, however, enhance PK activation, and facilitates FXII and FXI activation by FXII-T. There may be multiple effects that contribute to the mechanism involved. First, Poly-P-bound FXII-T may assume a conformation that enhances extended interaction with macromolecular substrates. It is also likely that the substrate (PK, FXII or FXI) is altered upon binding to Poly-P, exposing activation cleavage sites. Furthermore, the size dependence of the Poly-P-effect [41, 44] points to facilitation of protease and substrate binding in proximity to each other through a bridging (template) mechanism.
There is precedent for plasma serine proteases having activity in their single-chain forms, a property referred to as low zymogenisity. Single chain tissue plasminogen activator (tPA) is 8-fold less active against tripeptide substrates and 20-50-fold less active towards plasminogen than two-chain tPA [45] , but in the presence of fibrin both forms cleave plasminogen similarly. Renatus et al. proposed that a salt bridge between Lys156 and Asp194 in tPA (Fig8A) not found in most trypsin-like proteases contributes to formation of a functional active site in the single-chain protein [46] . Single-chain urokinase, also has activity toward plasminogen in the presence of fibrin and, like tPA, has lysine at position 156 [47] . Gln156
in FXII cannot form a stabilizing salt bridge with Asp194, but it may provide weak stabilization through hydrogen bonding interactions. In addition to forming a salt bridge with Lys156, the carboxylate group of Asp194 in tPA forms hydrogen bonds with the main-chain nitrogen atoms of Gly142 and Cys191 (Fig.8A ).
A homology model of FXII-T based on the tPA structure reveals that the FXII Asp194 carboxylate can form the same hydrogen bonds (Fig.8B ) [48] . Furthermore, because of additional hydrogen bond with the side-chain of Gln156, there is no impediment to oxyanion hole formation. Gln156 would be less effective at stabilizing Asp194 in FXII-T than the N-terminal Val16 in FXIIa, consistent with the lower catalytic 13 activity of FXII-T. Recently the crystal structure of FXII catalytic domain with Arg-Ser blocking the Nterminus (FXIIc) was reported [49] . FXIIc has a zymogen-like conformation, lacking the oxyanion hole, and Asp194 interacts with Arg73 in a configuration similar to the zymogen triad described for chymotrypsinogen (Fig. 8C) [50, 51] . This suggests a complex interplay of factors, including conformational changes within FXII induced by interactions with substrates, determine formation of a productive FXII-T enzyme-substrate complex, as has been proposed for other members of the trypsin-like protease family [52] .
Our results support a model for contact activation that does not require pre-existing FXIIa or -kallikrein.
Single-chain FXII would catalyze initial FXII and PK conversion to FXIIa and -kallikrein upon surface exposure. The relatively low activity of single-chain FXII suggests that it is FXIIa and -kallikrein that are responsible for subsequent acceleration of contact activation. This is consistent with the observation that progress curves for FXII autoactivation fit models based on initiation by traces of FXIIa [27, 28] .
Single-chain FXII activity is relevant early in contact activation when FXIIa concentration is low, but is progressively less important as FXIIa accumulates. Finally, our plasma-based studies indicate that while surface-bound single-chain FXII activates FXI, FXIIa is a considerably better activator, supporting the premise that the procoagulant and prothrombotic activities of FXII are mediated largely, if not exclusively, through FXIIa. The observation that single-chain FXII activates PK has interesting implications. While the reaction is several orders of magnitude less efficient than for FXIIa activation of PK, the plasma PK concentration (~600 nM) is near Km for fluid phase activation by FXII-T. Furthermore, under normal conditions the plasma concentration of FXII (~400 nM) is probably several orders of magnitude higher than that of FXIIa. This suggests that the relatively high plasma FXII level could compensate for the weak specific activity of single-chain FXII toward PK. Given this, single-chain FXII activity may contribute to the basal reciprocal turnover of FXII and PK observed in vivo [19] .
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